The role of paraoxonase (PON) enzyme in the extent and severity of the coronary artery disease in type-2 diabetic patients

Heart and Vessels

Volumn 22, Issue 3, 2007, Pages 158-164

  Tartan, Zeynep ^a,c   Orhan, Gokcen ^a   Kasikçioglu, Hulya ^a   Uyarel, Huseyin ^a   Unal, Sennur ^a   Ozer, Nihat ^a   Ozay, Batuhan ^a   Ciloglu, Figen ^b   Cam, Nese ^a  

^a Siyami Ersek Thoracic and Cardiovascular Surgery Hospital   (Turkey)

^b GenLab Genetic Medical Laboratories Istanbul   (Turkey)

^c NONE   (Turkey)

Author keywords

Coronary artery disease; Diabetes mellitus; Gensini score; Paraoxonase enzyme activity

Indexed keywords

APOLIPOPROTEIN A1; ARYLDIALKYLPHOSPHATASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; ORAL ANTIDIABETIC AGENT; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY DISEASE; CORRELATION COEFFICIENT; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; ENZYME ACTIVITY; FEMALE; HIGH RISK PATIENT; HUMAN; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL; SCORING SYSTEM;

ARYLDIALKYLPHOSPHATASE; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LINEAR MODELS; LIPID PEROXIDATION; MALE; MIDDLE AGED;

EID: 34249846668     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00380-006-0957-6     Document Type: Article

References (34)

1. JR Sowers 1998 Diabetes mellitus and cardiovascular disease in women Arch Intern Med 158 617-621 9521226 10.1001/archinte.158.6.617 1:STN:280:DyaK1c7otVGhsA%3D%3D
2. WB Kannel 1987 Metabolic risk factors for coronary heart disease in women: Perspective from the Framingham Study Am Heart J 114 413-419 3604900 10.1016/0002-8703(87)90511-4 1:STN:280:BiiB28jisl0%3D
3. American Diabetes Association 1998 Consensus Development Conference on the Diagnosis of Coronary Heart Disease in People with Diabetes. Miami, Florida, 10-11 February, 1998 Diabetes Care 21 1551-1559 10.2337/ diacare.21.9.1551
4. KK Griendling RW Alexander 1997 Oxidative stress and cardiovascular disease Circulation 96 3264-3265 9396412 1:STN:280:DyaK1c%2FlslSqug%3D%3D
5. M Aviram 2000 Review of human studies on oxidative damage and antioxidant protection related to cardiovascular diseases Free Radic Res 33 S85-S97 11191279 1:CAS:528:DC%2BD3MXjtVSntw%3D%3D
6. GM Chisolm KC Irwin MS Penn 1992 Lipoprotein oxidation and lipoprotein-induced cell injury in diabetes Diabetes 41 61-66 1526338 1:CAS:528:DyaK3sXnvVSktw%3D%3D
7. M Aviram 2004 Introduction to the serial review on paraoxonases, oxidative stress, and cardiovascular diseases Free Radic Biol Med 37 1301-1303 15454270 10.1016/j.freeradbiomed.2004.07.009 1:CAS:528:DC%2BD2cXnvFaiu70%3D
8. B Mackness MI Mackness S Arrol W Turkie PN Durington 1998 Effect of the human serum paraoxonase 55 and 192 genetic polymorphisms on the protection by high density lipoprotein against low density lipoprotein oxidative modification FEBS Lett 423 57-60 9506841 10.1016/ S0014-5793(98)00064-7 1:CAS:528:DyaK1cXhtVWgtrw%3D
9. JG Wheeler BD Keavney H Watkins R Collins J Danesh 2004 Four paraoxonase gene polymorphisms in 11 212 cases of coronary heart disease and 12 786 controls: Meta-analysis of 43 studies Lancet 363 689-695 15001326 10.1016/S0140-6736(04)15642-0 1:CAS:528:DC%2BD2cXhs12jur8%3D
10. GP Jarvik LS Rozek VH Brophy TS Hatsukami RJ Richter GD Schellenberg CE Furlong 2000 Paraoxonase (PON1) phenotype is a better predictor of vascular disease than is PON1 192 or PON1 55 genotype Arterioscler Thromb Vasc Biol 20 2441-2447 11073850 1:CAS:528:DC%2BD3cXptVSisLY%3D
11. B Mackness GK Davies W Turkie E Lee DH Roberts E Hill C Roberts PN Durrington MI Mackness 2001 Paraoxonase status in coronary heart disease. Are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol 21 1451-1457 11557671 1:CAS:528:DC%2BD3MXntVGku70%3D
12. MI Mackness D Harty D Bhatnagar PH Winocour S Arrol M Ishola PN Durington 1991 Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus Atherosclerosis 86 193-199 1651732 10.1016/0021-9150(91)90215-O 1:STN:280:By6A3sjitV0%3D
13. CA Abbott MI Mackness S Kumar AJ Boulton PN Durrington 1995 Serum paraoxonase activity, concentration, and phenotype distribution in diabetes mellitus and its relationship to serum lipids and lipoproteins Arterioscler Thromb Vasc Biol 15 1812-1818 7583560 1:CAS:528:DyaK28XhslChuw%3D%3D
14. KG Alberti PZ Zimmet 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation Diabet Med 15 539-553 9686693 10.1002/ (SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S 1:STN:280:DyaK1czkvFCrsA%3D%3D
15. SJ Kalbfleisch MJ McGillem IM Pinto KM Kavanaugh SF DeBoe GB Mancini 1990 Comparison of automated quantitative coronary angiography with caliper measurements of percent diameter stenosis Am J Cardiol 65 1181-1184 2337026 10.1016/0002-9149(90)90970-C 1:STN:280:By%2BB2cjivV0%3D
16. GG Gensini 1983 A more meaningful scoring system for determining the severity of coronary heart disease Am J Cardiol 51 6066823874 10.1016/ S0002-9149(83)80105-2 1:STN:280:BiyC38zotFE%3D
17. CE Furlong RJ Richter SL Seidel LG Costa AG Motulsky 1989 Spectrophotometric assays for the enzymatic hydrolysis of the active metabolites of chlorpyrifos and parathion by plasma paraoxonase/ arylesterase Anal Biochem 180 242-247 2479288 10.1016/ 0003-2697(89)90424-7 1:CAS:528:DyaL1MXlvV2qtrY%3D
18. K Yagi 1998 Simple assay for the level of total lipid peroxides in serum or plasma Methods Mol Biol 108 101-106 9921519 1:CAS:528:DyaK1cXlsFGhsL8%3D
19. I Tkac BP Kimball G Lewis K Uffelman G Steiner 1997 The severity of coronary atherosclerosis in type 2 diabetes mellitus is related to the number of circulating triglyceride-rich lipoprotein particles Atheroscler Thromb Vasc Biol 17 3633-3638 1:STN:280:DyaK1c%2FpvFylsw%3D%3D
20. B Fuhrman L Koren N Volkova S Keidar T Hayek M Aviram 2002 Atorvastatin therapy in hypercholesterolemic patients suppresses cellular uptake of oxidized-LDL by differentiating monocytes Atherosclerosis 164 179-185 12119208 10.1016/S0021-9150(02)00063-1 1:CAS:528:DC%2BD38Xlt12lt7c%3D
21. M Tomas M Senti F Garcia-Faria J Vila A Torrents M Covas J Marrugat 2000 Effect of simvastatin therapy on paraoxonase activity and related proteins in FH patients Arterioscler Thromb Vasc Biol 20 2113-2119 10978257 1:CAS:528:DC%2BD3cXntV2itLw%3D
22. S Wassmann U Laufs K Muller C Konkol K Ahlbory AT Baumer W Linz M Bohm G Nickening 2002 Cellular antioxidant effects of atorvastatin in-vitro and in-vivo Arterioscler Thromb Vasc Biol 22 300-305 11834532 10.1161/ hq0202.104081 1:CAS:528:DC%2BD38Xhtlyjsbg%3D
23. DM Shih YR Xia XP Wang E Miller LW Castellani G Subbanagounder H Cheroutre KF Faull JA Berliner JL Witztum AJ Luis 2000 Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis J Biol Chem 275 17527-17535 10748217 10.1074/jbc.M910376199 1:CAS:528:DC%2BD3cXktFaksbk%3D
24. EM Rubin RM Krauss EA Spangler JG Verstuyft SM Clift 1991 Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI Nature 353 265-267 1910153 10.1038/353265a0 1:CAS:528:DyaK3MXmtVKrsL0%3D
25. RC Sorenson CL Bisgaier M Aviram C Hsu S Billecke BN La Du 1999 Human serum Paraoxonase/arylesterase's retained hydrophobic N-terminal leader sequence associates with HDLs by binding phospholipids: Apolipoprotein A-I stabilizes activity Arterioscler Thromb Vasc Biol 19 2214-2225 10479665 1:CAS:528:DyaK1MXmtFOrtLw%3D
26. MC Phillips KL Gillotte MP Haynes WJ Johnson S Lund-Katz GH Rothblat 1998 Mechanisms of high density lipoprotein-mediated efflux of cholesterol from cell plasma membranes Atherosclerosis 137 Suppl S13-17 9694536 10.1016/S0021-9150(97)00312-2 1:CAS:528:DyaK1cXivVCmtb8%3D
27. E Nobecourt S Jacqueminet B Hansel S Chantepie A Grimaldi MJ Chapman A Kontush 2005 Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: Relationship to elevated oxidative stress and hyperglycaemia Diabetologia 48 529-538 15729582 10.1007/ s00125-004-1655-5 1:CAS:528:DC%2BD2MXisVCitbg%3D
28. MI Mackness S Arrol C Abbott PN Durrington 1993 Protection of low-density lipoprotein against oxidative modification by high-density lipoprotein associated paraoxonase Atherosclerosis 104 129-135 8141836 10.1016/0021-9150(93)90183-U 1:CAS:528:DyaK2cXlvFylsbo%3D
29. CC Hedrick SR Thorpe MX Fu CM Harper J Yoo SM Kim H Wong AL Peters 2000 Glycation impairs high-density lipoprotein function Diabetologia 43 312-320 10768092 10.1007/s001250050049 1:CAS:528:DC%2BD3cXhsFylur8%3D
30. MI Mackness S Arrol PN Durrington 1991 Paraoxonase prevents accumulation of lipoperoxides in low-density lipoprotein FEBS Lett 286 152-154 1650712 10.1016/0014-5793(91)80962-3 1:CAS:528:DyaK3MXltFWgu7Y%3D
31. Y Ikeda T Suehiro M Inoue Y Nakauchi T Morita K Arii H Ito Y Kumon K Hashimoto 1998 Serum paraoxonase activity and its relationship to diabetic complications in patients with non-insulin-dependent diabetes mellitus Metabolism 47 598-602 9591753 10.1016/S0026-0495(98)90246-3 1:CAS:528:DyaK1cXjtFertb8%3D
32. SP Wolff ZY Jiang JV Hunt 1991 Protein glycation and oxidative stress in diabetes mellitus and ageing Free Radic Biol Med 10 339-352 1855674 10.1016/0891-5849(91)90040-A 1:CAS:528:DyaK3MXktVKjsrY%3D
33. J Nourooz-Zadeh J Tajaddini-Sarmadi S McCarthy DJ Betteridge SP Wolff 1995 Elevated levels of authentic plasma hydroperoxides in NIDDM Diabetes 44 1054-1058 7657028 10.2337/diabetes.44.9.1054 1:CAS:528:DyaK2MXotVGhurY%3D
34. B Agaçhan H Yilmaz HA Ergen ZE Karaali T Isbir 2005 Paraoxonase (PON1) 55 and 192 Polymorphism and Its Effects to Oxidant-Antioxidant System in Turkish Patients with Type 2 Diabetes Mellitus Physiol Res 54 287-293 15974833